HR 2580
116th Congress
House
Crime and Law Enforcement
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Modernizing Drug Enforcement Act of 2019
Introduced: May 8, 2019
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 31, 2019
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
May 9, 2019
Referred to the Subcommittee on Health.
May 8, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 8, 2019
Introduced in House
Plain-English summary
Modernizing Drug Enforcement Act of 2019
This bill deems a drug or substance that acts as an opioid mu receptor agonist (e.g., morphine) to be in schedule I of the Controlled Substances Act, subject to certain exceptions. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
What's happening now
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Committees of jurisdiction
4
Cosponsors
1